Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04166877 · ClinicalTrials.gov registry record · Phase 4
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
A Phase 4 study of Trauma and Acute Pain, sponsored by University of California, Davis.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 156
- Enrollment target
- 1
- Study location
NCT04166877 is a Phase 4 study of Trauma and Acute Pain that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 156 participants, below the 305-participant average among 56 other Trauma trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04166877, a Phase 4 study of Trauma and Acute Pain, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 156 participants
- Enrollment target
- 1
- Study location
Study Summary
Magnesium is a naturally occurring mineral that is important for your body and brain. Magnesium sulfate (study drug) is a medication containing magnesium that is commonly used to improve low blood levels of magnesium. Magnesium sulfate has also proven to be successful in managing pain before and after surgery. However, this drug has primarily been used for pain control in patients undergoing surgery. Patients in the ICU with injuries also need good pain control. Using magnesium may assist in decreasing narcotic (pain reliever) requirements and provide another non-narcotic drug for pain control. The purpose of this study is to test the effectiveness of continuous, intravenous (into or within a vein using a needle) administration of magnesium sulfate for pain control in trauma patients admitted to the adult Intensive Care Unit. This will be compared to intravenous normal saline (salt solution).
Conditions Studied
Interventions
- DRUG Magnesium Sulfate in Parenteral Dosage Form
- DRUG Normal saline placebo
Study Locations (1)
California
- UC Davis Health - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2019-12-07 |
| Est. Completion | 2026-12-31 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04166877
The ClinicalTrials.gov registry entry for NCT04166877 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 156 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 305-participant average among 56 other Trauma trials with a reported enrollment target (49% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Trauma appearing as the primary indexed condition, and to 2 interventions - of which Magnesium Sulfate in Parenteral Dosage Form is the first listed.
NCT04166877 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04166877 about?
NCT04166877 is a clinical study titled "Magnesium Infusion for Pain Management in Critically Ill Trauma Patients". Magnesium is a naturally occurring mineral that is important for your body and brain. Magnesium sulfate (study drug) is a medication containing magnesium that is commonly used to improve low blood levels of magnesium. Magnesium sulfate has also proven to be successful in managing pain before and aft...
What is the current status of trial NCT04166877?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 156 participants. The study started on 2019-12-07. Estimated completion is 2026-12-31.
What conditions does trial NCT04166877 study?
This clinical trial studies the following conditions: Trauma, Acute Pain.
What interventions are being tested in trial NCT04166877?
The interventions under investigation include: Magnesium Sulfate in Parenteral Dosage Form (DRUG), Normal saline placebo (DRUG).
Who is sponsoring clinical trial NCT04166877?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04166877 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trauma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
RECRUITING · Phase 4
-
Nonopioid Pain Control Regimen After Open Reduction and Internal Fixation of Traumatic Fractures
RECRUITING · Phase 4
-
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
RECRUITING · Phase 2
-
Testing FIRST in Youth Outpatient Psychotherapy
RECRUITING · NA
-
PRESERVE & CONNECT: Impact Study of the BPC
RECRUITING · NA
-
Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.